Mesoblast receives J-Code for Ryoncil from Medicare & Medicaid Services

Mesoblast (MESO) announced that a specific Healthcare Common Procedure Coding System J-Code assigned to Ryoncil by United States Medicare & Medicaid Services became active for billing and reimbursement on October 1. The new permanent J-Code, J3402, provides a specific billing pathway for Ryoncil by Medicaid, facilitating reimbursement and broader patient access for this important therapy.